Transakt Stock Performance
TAKD Stock | USD 0.01 0.02 81.61% |
TransAKT holds a performance score of 7 on a scale of zero to a hundred. The entity has a beta of -13.35, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning TransAKT are expected to decrease by larger amounts. On the other hand, during market turmoil, TransAKT is expected to outperform it. Use TransAKT variance, kurtosis, period momentum indicator, as well as the relationship between the total risk alpha and day median price , to analyze future returns on TransAKT.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in TransAKT are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent forward-looking signals, TransAKT exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow | 435.6 K | |
Free Cash Flow | -208.7 K |
TransAKT |
TransAKT Relative Risk vs. Return Landscape
If you would invest 10.00 in TransAKT on December 17, 2024 and sell it today you would lose (9.45) from holding TransAKT or give up 94.5% of portfolio value over 90 days. TransAKT is currently generating 4.0181% in daily expected returns and assumes 40.4521% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than TransAKT, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
TransAKT Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for TransAKT's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as TransAKT, and traders can use it to determine the average amount a TransAKT's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0993
Best Portfolio | Best Equity | TAKD | ||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
40.45 actual daily | 96 96% of assets are less volatile |
Expected Return
4.02 actual daily | 80 80% of assets have lower returns |
Risk-Adjusted Return
0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average TransAKT is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of TransAKT by adding it to a well-diversified portfolio.
TransAKT Fundamentals Growth
TransAKT Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of TransAKT, and TransAKT fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on TransAKT Pink Sheet performance.
Return On Equity | -1.01 | |||
Return On Asset | -0.57 | |||
Current Valuation | 4.66 M | |||
Shares Outstanding | 133.51 M | |||
Price To Book | 45.71 X | |||
EBITDA | (208.31 K) | |||
Cash And Equivalents | 128.58 K | |||
Debt To Equity | 0.46 % | |||
Book Value Per Share | 0 X | |||
Cash Flow From Operations | (208.68 K) | |||
Earnings Per Share | (0) X | |||
Total Asset | 239.09 K | |||
Retained Earnings | (23.18 M) | |||
Current Asset | 727 K | |||
Current Liabilities | 1.06 M | |||
About TransAKT Performance
By analyzing TransAKT's fundamental ratios, stakeholders can gain valuable insights into TransAKT's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if TransAKT has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if TransAKT has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
TransAKT Ltd., through its subsidiary, TransAKT Bio Agritech Ltd., engages in the research and development of agricultural technology. The company was incorporated in 1996 and is based in Fo Tan, Hong Kong. Transakt is traded on OTC Exchange in the United States.Things to note about TransAKT performance evaluation
Checking the ongoing alerts about TransAKT for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for TransAKT help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.TransAKT is way too risky over 90 days horizon | |
TransAKT has some characteristics of a very speculative penny stock | |
TransAKT appears to be risky and price may revert if volatility continues | |
Net Loss for the year was (208.31 K) with profit before overhead, payroll, taxes, and interest of 0. | |
TransAKT currently holds about 128.58 K in cash with (208.68 K) of positive cash flow from operations. | |
Roughly 83.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing TransAKT's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether TransAKT's stock is overvalued or undervalued compared to its peers.
- Examining TransAKT's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating TransAKT's management team can have a significant impact on its success or failure. Reviewing the track record and experience of TransAKT's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of TransAKT's pink sheet. These opinions can provide insight into TransAKT's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for TransAKT Pink Sheet analysis
When running TransAKT's price analysis, check to measure TransAKT's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransAKT is operating at the current time. Most of TransAKT's value examination focuses on studying past and present price action to predict the probability of TransAKT's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransAKT's price. Additionally, you may evaluate how the addition of TransAKT to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |